Syndrome News and Research

RSS

Heavy rainfall can help predict mosquito-borne virus outbreaks

A new study demonstrates that outbreaks of mosquito-borne viruses Zika and Chikungunya generally occur about three weeks after heavy rainfall.

22 Nov 2017

Metabolic factors in conjunction with alcohol consumption increase risk of severe liver disease

A new study provides insights into the interaction between alcohol consumption and metabolic factors in predicting severe liver disease in the general population.

22 Nov 2017

UNC Lineberger professor receives The Leukemia & Lymphoma Society grant for immunotherapy research

UNC Lineberger Comprehensive Cancer Center researcher Barbara Savoldo, MD, PhD, was awarded a $600,000, three-year grant from The Leukemia & Lymphoma Society to support research into an immunotherapy treatment being developed with a "safety switch" to safeguard against potential side effects of the treatment.

21 Nov 2017

Liver disease in children with Alagille Syndrome caused by malformations of bile ducts

Serious liver and heart problems can affect children with Alagille Syndrome early in life. While there is as yet no cure, researchers at Karolinska Institutet in Sweden have discovered that the liver disease part of the syndrome is caused by specific malformations of the bile ducts.

21 Nov 2017

New technique may reveal clues about role of centromeres in Down syndrome, other birth defects

Some scientists call it the "final frontier" of our DNA -- even though it lies at the center of every X-shaped chromosome in nearly every one of our cells.

20 Nov 2017

Experts endorse recommendations for restrictive blood transfusions

By analyzing data from randomized clinical trials comparing blood transfusion approaches, Johns Hopkins experts, along with colleagues at Cleveland Clinic and NYU Langone Medical Center, endorse recommendations for blood transfusions that reduce blood use to improve patient safety and outcomes.

20 Nov 2017

Researchers identify three specific molecules that accurately indicate pre-diabetes

Researchers from the University of Sydney's Charles Perkins Centre have identified three specific molecules that accurately indicate insulin resistance, or pre-diabetes - a major predictor of metabolic syndrome, the collection of medical conditions that include abdominal obesity, high blood pressure and high blood sugar levels.

20 Nov 2017

Heart break could lead to severe and long term heart damage

Heart break is actually damaging for the heart finds a new study. Researchers have found that persons undergoing a heart break could suffer from damages to the heart that is similar to heart attacks.

19 Nov 2017

Gene editing within a living person for the first time

Genetic editing has been performed in the laboratory until now. Living cells within Petri-dishes have been put under the microscope while gene editing tools such as CRISPR were used to cut, nick and replace parts of the DNA or genome that is defective with bits of DNA that is correct in its sequence. Now doctors in California have attempted to edit cells within a living person.

19 Nov 2017

New study further validates use of vaginal progesterone to decrease risk of preterm birth

A new study published today - World Prematurity Day - in the American Journal of Obstetrics & Gynecology provides additional support for treatment with vaginal progesterone to reduce the risk of preterm birth, neonatal complications and infant death in pregnant women with a short cervix.

17 Nov 2017

ASU professor reveals more about craniofacial conditions before release of ‘Wonder’

The new film "Wonder" tells the story of a young boy who overcomes the challenges of living with the facial structural abnormality known as Treacher Collins Syndrome.

17 Nov 2017

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

The U.S. Food and Drug Administration today approved Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at a high risk of kidney cancer (renal cell carcinoma) returning after a kidney has been removed (nephrectomy).

17 Nov 2017

FDA approves drug to treat pediatric, adult patients with rare Sly syndrome

The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome. MPS VII is an extremely rare, progressive condition that affects most tissues and organs.

15 Nov 2017

Tulane professor wins Department of Defense grant for research into arteriovenous malformations

Tulane University's Stryder Meadows, a cell and molecular biology professor, received a $1.7 million grant from the Department of Defense to study how arteriovenous malformations (AVM), which are defects in arteries, veins and capillaries, form Hereditary Hemorrhagic Telangiectasia (HHT), a genetic disorder that affects about 1 in 5,000 people.

14 Nov 2017

New drug shows promise in mouse model of autism disorder

Scientists have performed a successful test of a possible new drug in a mouse model of an autism disorder. The candidate drug, called NitroSynapsin, largely corrected electrical, behavioral and brain abnormalities in the mice.

14 Nov 2017

Advances in genetic and stem cell techniques help identify therapeutic targets for neurological disorders

Research released today highlights advances in the use of CRISPR-Cas9 and human induced pluripotent stem cell technologies to identify novel therapeutic targets for neurological disorders such as schizophrenia and addiction.

13 Nov 2017

Researchers find distinct molecular signatures in chronic fatigue syndrome and Gulf War Illness

Researchers at Georgetown University Medical Center have found distinct molecular signatures in two brain disorders long thought to be psychological in origin -- chronic fatigue syndrome (CFS) and Gulf War Illness (GWI).

10 Nov 2017

Increasing hydroxyurea dose linked to reduction in hospitalization for young sickle cell anemia patients

St. Jude Children's Research Hospital investigators have shown that using the drug hydroxyurea to boost average fetal hemoglobin levels above 20 percent in children and teenagers with sickle cell anemia was associated with at least a two-fold reduction in hospitalization for any reason.

9 Nov 2017

MGH researchers identify first effective treatment option for autoimmune small-fiber polyneuropathy

An analysis of the medical records of patients treated at Massachusetts General Hospital (MGH) for an often-mysterious condition involving damage to small nerve fibers supports the hypothesis that some cases are caused by autoimmune disease and also identifies the first effective treatment option.

9 Nov 2017

Women with ER-positive breast cancer face disease recurrence risk years after treatment ends

Even 20 years after a diagnosis, women with a type of breast cancer fueled by estrogen still face a substantial risk of cancer returning or spreading, according to a new analysis from an international team of investigators published in the New England Journal of Medicine.

9 Nov 2017

Syndrome News and Research

Heavy rainfall can help predict mosquito-borne virus outbreaks

Metabolic factors in conjunction with alcohol consumption increase risk of severe liver disease

UNC Lineberger professor receives The Leukemia & Lymphoma Society grant for immunotherapy research

Liver disease in children with Alagille Syndrome caused by malformations of bile ducts

New technique may reveal clues about role of centromeres in Down syndrome, other birth defects

Experts endorse recommendations for restrictive blood transfusions

Researchers identify three specific molecules that accurately indicate pre-diabetes

Heart break could lead to severe and long term heart damage

Gene editing within a living person for the first time

New study further validates use of vaginal progesterone to decrease risk of preterm birth

ASU professor reveals more about craniofacial conditions before release of ‘Wonder’

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

FDA approves drug to treat pediatric, adult patients with rare Sly syndrome

Tulane professor wins Department of Defense grant for research into arteriovenous malformations

New drug shows promise in mouse model of autism disorder

Advances in genetic and stem cell techniques help identify therapeutic targets for neurological disorders

Researchers find distinct molecular signatures in chronic fatigue syndrome and Gulf War Illness

Increasing hydroxyurea dose linked to reduction in hospitalization for young sickle cell anemia patients

MGH researchers identify first effective treatment option for autoimmune small-fiber polyneuropathy

Women with ER-positive breast cancer face disease recurrence risk years after treatment ends

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News